MedTrace Logo

Varenicline for Light Smokers

NCT01639560 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2018-02-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if varenicline is effective in treating tobacco dependence in adults who smoke 5-10 cigarettes per day.

Conditions

  • Smoking

Interventions

DRUG

Varenicline

1 mg of varenicline twice per day for 12 weeks and brief behavioral counseling

DRUG

Placebo

1 placebo tablet twice per day for 12 weeks and brief behavioral counseling

Sponsors & Collaborators

Principal Investigators

  • Jon O. Ebbert, MD · Mayo Clinic

  • Ivana T. Croghan, PhD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-12-31
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639560 on ClinicalTrials.gov